We are live on ! Find out more
CLOV icon

Clover Health Investments
CLOV

175 hedge funds and large institutions have $210M invested in Clover Health Investments in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 58 increasing their positions, 39 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $7.99M | Put options by funds: $4.94M

49% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 39

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 25

0.09% less ownership

Funds ownership: 32.28% → 32.19% (-0.09%)

1% less funds holding

Funds holding: 176 → 175 (-1)

20% less capital invested

Capital invested by funds: $262M → $210M (-$52.5M)

Holders
175
Holders Change
-1
Holders Change %
-0.57%
% of All Funds
3.01%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
25
Increased
58
Reduced
39
Closed
25
Calls
$7.99M
Puts
$4.94M
Net Calls
+$3.05M
Net Calls Change
-$3.58M

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$6.16M
2
BlackRock
BlackRock
New York
+$3.8M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$1.29M
4
N
Nuveen
North Carolina
+$1.24M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.07M

Top Sellers

1
Two Sigma Advisers
Two Sigma Advisers
New York
-$5.66M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$3.1M
3
GCM
Graham Capital Management
Connecticut
-$2.12M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.85M
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$1.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$52.5M -$3.1M -1,184,945 -4%
BlackRock
2
BlackRock
New York
$44M +$3.8M +1,452,210 +6%
State Street
3
State Street
Massachusetts
$13.9M +$537K +205,043 +3%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$10.6M +$624K +238,217 +4%
PNC Financial Services Group
5
PNC Financial Services Group
Pennsylvania
$9.96M -$917K -350,183 -6%
Renaissance Technologies
6
Renaissance Technologies
New York
$6.77M +$6.16M +2,351,160 +144%
Northern Trust
7
Northern Trust
Illinois
$5.88M -$373K -142,416 -4%
Baillie Gifford & Co
8
Baillie Gifford & Co
United Kingdom
$4.5M – – –
Charles Schwab
9
Charles Schwab
California
$4.27M +$444K +169,657 +7%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$4.23M +$14.6K +5,561 +0.2%
JAM
11
Jupiter Asset Management
United Kingdom
$4.02M -$780K -297,863 -11%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$3.62M +$1.06M +404,578 +23%
HSCM
13
Hudson Structured Capital Management
Connecticut
$3.36M – – –
N
14
Nuveen
North Carolina
$3.03M +$1.24M +474,829 +36%
PA
15
Perceptive Advisors
New York
$2.55M – – –
Bank of New York Mellon
16
Bank of New York Mellon
New York
$2.47M +$375K +143,249 +11%
Morgan Stanley
17
Morgan Stanley
New York
$2.37M +$394K +150,518 +12%
Goldman Sachs
18
Goldman Sachs
New York
$1.37M +$193K +73,643 +10%
Bank of America
19
Bank of America
North Carolina
$1.35M +$909K +347,106 +77%
Qube Research & Technologies (QRT)
20
Qube Research & Technologies (QRT)
United Kingdom
$1.31M +$1.29M +493,989 +179%
Swiss National Bank
21
Swiss National Bank
Switzerland
$1.3M +$15.5K +5,900 +0.8%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$1.22M -$5.66M -2,161,000 -75%
GCM
23
Graham Capital Management
Connecticut
$1.21M -$2.12M -808,429 -53%
CSS
24
Cubist Systematic Strategies
Connecticut
$1.08M +$958K +365,875 +136%
SFI
25
Susquehanna Fundamental Investments
Pennsylvania
$1.04M +$1.6M +609,362 New
1
2 3 4 5

CLOV Hedge Fund Activity: Q3 2022 in Review

175 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q3 2022, worth a combined $210M — down 20% from $262M a quarter earlier.

Fund positioning in CLOV was balanced in Q3 2022: 25 funds opened new positions, 25 closed out, 58 added to existing stakes and 39 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $6.16M. The largest seller was Two Sigma Advisers, cutting an estimated $5.66M.

  • 175 institutional investors held Clover Health Investments (CLOV) as of Q3 2022, down from 176 in Q2 2022.
  • Funds reported $210M of Clover Health Investments stock for Q3 2022, down 20% quarter-over-quarter.
  • 25 funds opened new Clover Health Investments positions in Q3 2022 and 25 closed out, a net change of 0 holders.
  • The largest Clover Health Investments buyer in Q3 2022 was Renaissance Technologies, an estimated $6.16M added.
  • The largest Clover Health Investments seller in Q3 2022 was Two Sigma Advisers, an estimated $5.66M sold.

Based on aggregated 13F filings for Q3 2022.